Morgan Stanley Maintains Overweight on Equifax, Lowers Price Target to $225

Benzinga Newsdesk www.benzinga.com Negative 91.2%

Neg 91.2% Neu 0% Pos 0%

Morgan Stanley analyst Toni Kaplan maintains Equifax (NYSE:EFX) with a Overweight and lowers the price target from $243 to $225.